EUCTR2004-003953-16-IT进行中（未招募）不适用
A one-year,open-label,single arm, multi-center trial evaluating the efficacy and safety of oral ICL670 (20 mg/kg/day) in patients diagnosed with transfusion-dependent iron overload.
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 1,541
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •see protocol
- •Are the trial subjects under 18? yes
- •Number of subjects for this age range: 0
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •see protocol
研究者
相似试验
进行中（未招募）
不适用
A one-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral ICL670 (20 mg/kg/day) in patients diagnosed with transfusion-dependent iron overloadEUCTR2004-003953-16-DEovartis Pharma Services AG1,541
进行中（未招募）
不适用
A one-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral ICL670 (20 mg/kg/day) in patients diagnosed with transfusion-dependent iron overload.EUCTR2004-003953-16-ATovartis Pharma Services AG1,541
进行中（未招募）
不适用
A one-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral ICL670 (20 mg/kg/day) in patients three to six months after allogeneic hematopoietic cell transplantation in whom iron overload is presentEUCTR2006-003970-89-DEovartis Pharma GmbH
进行中（未招募）
不适用
A one-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral ICL670 (20 mg/kg/day) in patients diagnosed with transfusion-dependent iron overloadEstudio multicéntrico, abierto, de un solo grupo y de un año de duración, para evaluar la eficacia y seguridad de ICL670 (20 mg/kg/día) administrado vía oral en pacientes diagnosticados de sobrecarga férrica asociada a transfusionesEUCTR2004-003953-16-ESovartis Farmacéutica, S.A.1,541
进行中（未招募）
1 期
A one-year, open-label, single arm, multi-center trial evaluating the efficacy and safety of oral ICL670 (20 mg/kg/day) in patients diagnosed with transfusion-dependent iron overload.EUCTR2004-003953-16-BEovartis Pharma Services AG1,541